Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proceedings of the National Academy of Sciences, vol.95, issue.7, pp.3597-3602, 1998. ,
DOI : 10.1073/pnas.95.7.3597
Bone Resorption by Osteoclasts, Science, vol.289, issue.5484, pp.1504-1508, 2000. ,
DOI : 10.1126/science.289.5484.1504
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism, Proceedings of the National Academy of Sciences, vol.97, issue.4, pp.1566-1571, 2000. ,
DOI : 10.1073/pnas.97.4.1566
Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice, Genes to Cells, vol.7, issue.6, pp.353-362, 1999. ,
DOI : 10.1038/345442a0
Requirement for NF-kappaB in osteoclast and B-cell development, Genes Dev, vol.11, 1997. ,
Osteoprotegerin Production by Human Osteoblast Lineage Cells Is Stimulated by Vitamin D, Bone Morphogenetic Protein-2, and Cytokines, Biochemical and Biophysical Research Communications, vol.250, issue.3, pp.776-7819394, 1998. ,
DOI : 10.1006/bbrc.1998.9394
Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-??B Ligand: Modulation of the Expression by Osteotropic Factors and Cytokines, Biochemical and Biophysical Research Communications, vol.275, issue.3, pp.768-7753379, 2000. ,
DOI : 10.1006/bbrc.2000.3379
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis, Annals of the Rheumatic Diseases, vol.61, issue.12, 2002. ,
DOI : 10.1136/ard.61.12.1047
Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor, 2\250:AID- ANR3[3.0.CO, pp.250-258, 2000. ,
DOI : 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P
Critical Roles for Interleukin 1 and Tumor Necrosis Factor ?? in Antibody-induced Arthritis, The Journal of Experimental Medicine, vol.10, issue.1, pp.77-85, 2002. ,
DOI : 10.1016/S0140-6736(89)90430-3
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis, EMBO J, vol.10, pp.4025-4031, 1991. ,
Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody, Biochemical and Biophysical Research Communications, vol.347, issue.1, pp.124-132, 2006. ,
DOI : 10.1016/j.bbrc.2006.06.098
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women, Journal of Bone and Mineral Research, vol.273, issue.7, pp.1059-1066, 2004. ,
DOI : 10.1359/JBMR.040305
Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis, Clinical and Experimental Immunology, vol.107, issue.2, pp.248-253, 1997. ,
DOI : 10.1111/j.1365-2249.1997.263-ce1154.x
Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils, Journal of Leukocyte Biology, vol.78, issue.1, pp.279-288, 2005. ,
DOI : 10.1189/jlb.1004612
Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis, Journal of Clinical Immunology, vol.247, issue.Suppl 97, pp.205-212, 1991. ,
DOI : 10.1007/BF00917426
Association of enhanced superoxide generation by neutrophils with low superoxide scavenging activity of the peripheral blood, joint fluid, and their leukocyte components in rheumatoid arthritis: effects of slow-acting anti-rheumatic drugs and disease activity, Clin Exp Rheumatol, vol.9, pp.149-155, 1991. ,
The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy, Cytokine, vol.41, issue.1, pp.16-23, 2008. ,
DOI : 10.1016/j.cyto.2007.10.004
Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-??-induced genes in bone cells, Journal of Leukocyte Biology, vol.77, issue.3, pp.388-399, 2005. ,
DOI : 10.1189/jlb.0904490
Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils, Arthritis Research & Therapy, vol.9, issue.2, pp.10-1186, 2007. ,
DOI : 10.1186/ar2137
Osteoarthritis cartilage histopathology: grading and staging, Osteoarthritis and Cartilage, vol.14, issue.1, pp.13-29, 2006. ,
DOI : 10.1016/j.joca.2005.07.014
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density, Cell, vol.89, issue.2, pp.309-319, 1997. ,
DOI : 10.1016/S0092-8674(00)80209-3
Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease, Arthritis Research & Therapy, vol.10, issue.5, pp.10-1186, 2008. ,
DOI : 10.1186/ar2518
Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus, Endocrinology, vol.142, pp.1419-1426, 2001. ,
Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists, Annals of the Rheumatic Diseases, vol.66, issue.12, pp.1675-1678, 2007. ,
DOI : 10.1136/ard.2007.071910
High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-??B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis, Clinical Biochemistry, vol.41, issue.9, pp.746-749, 2008. ,
DOI : 10.1016/j.clinbiochem.2008.02.011
Inflammatory response in patients with active and inactive osteoarthritis, Rheumatology International, vol.119, issue.10, pp.1197-1203, 2009. ,
DOI : 10.1007/s00296-009-0864-0
URL : https://hal.archives-ouvertes.fr/pasteur-00709228